Buy Vabysmo (faricimab-svoa) Online
DISEASE INDICATIONS: Macular Degeneration MANUFACTURER: Roche Registration Limited USAGE: Intravitreal MEDICINE APPROVED BY: Food and Drug Administration (FDA) Vabysmo (faricimab-svoa) is a prescribed medication utilized for managing two of the principal causes of visual impairment - neovascular or "wet" age-related macular degeneration (nAMD) and diabetic macular edema (DME).
$1,273.80
Select optionsThis product has multiple variants. The options may be chosen on the product page